Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tanimilast (CHF-6001) is a novel, potent, and selective phosphodiesterase 4 inhibitor with an IC50 value of 0.026 ± 0.006 nM. It exhibits potent anti-inflammatory activity and is indicated for topical use in the lungs. Tanimilast was studied for its effects on obstructive lung disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $233 | In Stock | |
5 mg | $579 | In Stock | |
10 mg | $868 | In Stock | |
25 mg | $1,460 | In Stock | |
50 mg | $1,970 | In Stock | |
100 mg | $2,650 | In Stock |
Description | Tanimilast (CHF-6001) is a novel, potent, and selective phosphodiesterase 4 inhibitor with an IC50 value of 0.026 ± 0.006 nM. It exhibits potent anti-inflammatory activity and is indicated for topical use in the lungs. Tanimilast was studied for its effects on obstructive lung disease. |
Targets&IC50 | PDE4:0.026±0.006 nM |
In vitro | Methacholine-induced protein expression of smooth muscle-myosin was fully inhibited by CHF-6001 (0.3-100 nM; Guinea pig precision-cut lung slices). CHF-6001 did not affect airway closure and had limited effects on TGF-β1-induced remodeling, but rather, it inhibited methacholine-induced TGF-β release.[2] |
Alias | CHF-6001 |
Molecular Weight | 687.54 |
Formula | C30H30Cl2F2N2O8S |
Cas No. | 1239278-59-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (72.72 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.